LuCE joins our European colleagues in calling for the protection of the EU Council Recommendations on cancer screening. The implementation of Low Dose CT (LDCT) screening is the best option to deliver a stage shift in the diagnosis of lung cancer. It can save the lives of many of our loved ones through earlier diagnosis.
The integrity of the EU’s Scientific advice mechanism must be preserved. Read the full European Cancer Organisation statement here – https://www.europeancancer.org/screening which is fully supported by LuCE.